Literature DB >> 20447076

Eosinophils in health and disease: the LIAR hypothesis.

J J Lee1, E A Jacobsen, M P McGarry, R P Schleimer, N A Lee.   

Abstract

Discussions of eosinophils are often descriptions of end-stage effector cells with destructive capabilities mediated predominantly by released cytotoxic cationic granule proteins. Moreover, eosinophils in the medical literature are invariably associated with the pathologies linked with helminth infections or allergic diseases such as asthma. This has led to an almost fatalist view of eosinophil effector functions and associated therapeutic strategies targeting these cells that would make even William of Ockham proud - eosinophil effector functions have physiological consequences that increase patient morbidity/mortality and 'the only good eosinophils are dead eosinophils'. Unfortunately, the strengths of dogmas are also their greatest weaknesses. Namely, while the repetitive proclamation of dogmatic concepts by authoritative sources (i.e. reviews, meeting proceedings, textbooks, etc.) builds consensus within the medical community and lower the entropies surrounding difficult issues, they often ignore not easily explained details and place diminished importance on alternative hypotheses. The goal of this perspective is twofold: (i) we will review recent observations regarding eosinophils and their activities as well as reinterpret earlier data as part of the synthesis of a new paradigm. In this paradigm, we hypothesize that eosinophils accumulate at unique sites in response to cell turnover or in response to local stem cell activity(ies). We further suggest that this accumulation is part of one or more mechanisms regulating tissue homeostasis. Specifically, instead of immune cells exclusively mediating innate host defence, we suggest that accumulating tissue eosinophils are actually regulators of Local Immunity And/or Remodeling/Repair in both health and disease - the LIAR hypothesis; (ii) we want to be inflammatory (pun intended!) and challenge the currently common perspective of eosinophils as destructive end-stage effector cells. Our hope is to create more questions than we answer and provoke everyone to spend countless hours simply to prove us wrong!

Entities:  

Mesh:

Year:  2010        PMID: 20447076      PMCID: PMC2951476          DOI: 10.1111/j.1365-2222.2010.03484.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  78 in total

Review 1.  Eosinophil infiltration and degranulation in normal human tissues: evidence for eosinophil degranulation in normal gastrointestinal tract.

Authors:  M Kato; G M Kephart; A Morikawa; G J Gleich
Journal:  Int Arch Allergy Immunol       Date:  2001       Impact factor: 2.749

2.  Broad phylogenomic sampling improves resolution of the animal tree of life.

Authors:  Casey W Dunn; Andreas Hejnol; David Q Matus; Kevin Pang; William E Browne; Stephen A Smith; Elaine Seaver; Greg W Rouse; Matthias Obst; Gregory D Edgecombe; Martin V Sørensen; Steven H D Haddock; Andreas Schmidt-Rhaesa; Akiko Okusu; Reinhardt Møbjerg Kristensen; Ward C Wheeler; Mark Q Martindale; Gonzalo Giribet
Journal:  Nature       Date:  2008-03-05       Impact factor: 49.962

3.  Eosinophils in asthma--closing the loop or opening the door?

Authors:  Sally E Wenzel
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

Review 4.  Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors.

Authors:  Ramin Lotfi; James J Lee; Michael T Lotze
Journal:  J Immunother       Date:  2007-01       Impact factor: 4.456

Review 5.  Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology?

Authors:  N A Lee; E W Gelfand; J J Lee
Journal:  J Allergy Clin Immunol       Date:  2001-06       Impact factor: 10.793

6.  Eotaxin is required for eosinophil homing into the stroma of the pubertal and cycling uterus.

Authors:  V Gouon-Evans; J W Pollard
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

7.  Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially.

Authors:  Lisa A Spencer; Craig T Szela; Sandra A C Perez; Casey L Kirchhoffer; Josiane S Neves; Amy L Radke; Peter F Weller
Journal:  J Leukoc Biol       Date:  2008-10-07       Impact factor: 4.962

Review 8.  Eosinophils and Trichinella infection: toxic for the parasite and the host?

Authors:  Fabrizio Bruschi; Masataka Korenaga; Naohiro Watanabe
Journal:  Trends Parasitol       Date:  2008-08-21

9.  Eosinophil deficiency compromises parasite survival in chronic nematode infection.

Authors:  Valeria Fabre; Daniel P Beiting; Susan K Bliss; Nebiat G Gebreselassie; Lucille F Gagliardo; Nancy A Lee; James J Lee; Judith A Appleton
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

Review 10.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development.

Authors:  Valérie Gouon-Evans; Elaine Y Lin; Jeffrey W Pollard
Journal:  Breast Cancer Res       Date:  2002-06-25       Impact factor: 6.466

View more
  139 in total

Review 1.  Eosinophils: important players in humoral immunity.

Authors:  C Berek
Journal:  Clin Exp Immunol       Date:  2015-09-28       Impact factor: 4.330

2.  CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue.

Authors:  W Reid Bolus; Dario A Gutierrez; Arion J Kennedy; Emily K Anderson-Baucum; Alyssa H Hasty
Journal:  J Leukoc Biol       Date:  2015-05-01       Impact factor: 4.962

Review 3.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.

Authors:  Hiam Abdala-Valencia; Mackenzie E Coden; Sergio E Chiarella; Elizabeth A Jacobsen; Bruce S Bochner; James J Lee; Sergejs Berdnikovs
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

4.  Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice.

Authors:  E A Jacobsen; A D Doyle; D C Colbert; K R Zellner; C A Protheroe; W E LeSuer; N A Lee; J J Lee
Journal:  Allergy       Date:  2015-06-14       Impact factor: 13.146

5.  Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model.

Authors:  Selene Colon; Haiyan Luan; Yan Liu; Cameron Meyer; Leslie Gewin; Gautam Bhave
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-19

Review 6.  Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Authors:  Zhaleh J Amini-Vaughan; Margarita Martinez-Moczygemba; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

7.  Probing the immune and healing response of murine intestinal mucosa by time-lapse 2-photon microscopy of laser-induced lesions with real-time dosimetry.

Authors:  Regina Orzekowsky-Schroeder; Antje Klinger; Sebastian Freidank; Norbert Linz; Sebastian Eckert; Gereon Hüttmann; Andreas Gebert; Alfred Vogel
Journal:  Biomed Opt Express       Date:  2014-09-10       Impact factor: 3.732

8.  Molecular Biology of Eosinophils: Introduction.

Authors:  Paige Lacy; Helene F Rosenberg; Garry M Walsh
Journal:  Methods Mol Biol       Date:  2021

9.  Frontline Science: Eosinophil-deficient MBP-1 and EPX double-knockout mice link pulmonary remodeling and airway dysfunction with type 2 inflammation.

Authors:  Sergei I Ochkur; Alfred D Doyle; Elizabeth A Jacobsen; William E LeSuer; Wen Li; Cheryl A Protheroe; Katie R Zellner; Dana Colbert; HuaHao H Shen; Charlie G Irvin; James J Lee; Nancy A Lee
Journal:  J Leukoc Biol       Date:  2017-05-17       Impact factor: 4.962

10.  Loss of hypoxia-inducible factor 2 alpha in the lung alveolar epithelium of mice leads to enhanced eosinophilic inflammation in cobalt-induced lung injury.

Authors:  Steven P Proper; Yogesh Saini; Krista K Greenwood; Lori A Bramble; Nathaniel J Downing; Jack R Harkema; John J Lapres
Journal:  Toxicol Sci       Date:  2013-11-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.